Adjunct therapy with probiotics for depressive episodes of bipolar disorder type Ⅰ: A randomized placebo-controlled trial
Background: Probiotics adjuvant therapy might enhance the efficacy of the conventional medications of bipolar disorder type Ⅰ (BD-Ⅰ). Methods: A randomized double-blind placebo-controlled design was implemented in this study. We randomly assigned 98 patients with depressive BD-Ⅰ to receive the combi...
Main Authors: | Jian-zhao Zhang, Fang-yuan Zhu, En-xu Feng, Fei Wu, Xin Fang, Huai-jun Tu, Jin Wei, Ai-lan Wan, Ting-tao Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Journal of Functional Foods |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1756464623001536 |
Similar Items
-
Research progress of the role of gut microbiota in the pathogenesis and treatment of bipolar disorder
by: Chu Lingli, et al.
Published: (2021-08-01) -
A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo
by: Michael Berk, et al.
Published: (2019-01-01) -
Effect of Probiotic Supplements on Oxidative Stress Biomarkers in First-Episode Bipolar Disorder Patients: A Randomized, Placebo-Controlled Trial
by: Cuirong Zeng, et al.
Published: (2022-04-01) -
Effect of <i>Lacticaseibacillus paracasei</i> Strain Shirota on Improvement in Depressive Symptoms, and Its Association with Abundance of Actinobacteria in Gut Microbiota
by: Machiko Otaka, et al.
Published: (2021-05-01) -
The Efficacy of Probiotics for Treatment of Bipolar Disorder-Type 1: A Randomized, Double-Blind, Placebo Controlled Trial
by: Mahin Eslami Shahrbabaki, et al.
Published: (2020-02-01)